KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Total Debt (2016 - 2024)

Historic Total Debt for Exact Sciences (EXAS) over the last 16 years, with Q1 2024 value amounting to $50.0 million.

  • Exact Sciences' Total Debt changed 0.0% to $50.0 million in Q1 2024 from the same period last year, while for Mar 2024 it was $50.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $50.0 million for FY2023, which is 0.0% changed from last year.
  • Per Exact Sciences' latest filing, its Total Debt stood at $50.0 million for Q1 2024, which was down 0.0% from $50.0 million recorded in Q4 2023.
  • Over the past 5 years, Exact Sciences' Total Debt peaked at $50.0 million during Q2 2022, and registered a low of $21.4 million during Q3 2021.
  • In the last 5 years, Exact Sciences' Total Debt had a median value of $50.0 million in 2022 and averaged $38.1 million.
  • As far as peak fluctuations go, Exact Sciences' Total Debt plummeted by 9333.83% in 2020, and later surged by 13323.07% in 2022.
  • Quarter analysis of 5 years shows Exact Sciences' Total Debt stood at $22.3 million in 2020, then dropped by 4.05% to $21.4 million in 2021, then surged by 133.23% to $50.0 million in 2022, then changed by 0.0% to $50.0 million in 2023, then changed by 0.0% to $50.0 million in 2024.
  • Its last three reported values are $50.0 million in Q1 2024, $50.0 million for Q4 2023, and $50.0 million during Q3 2023.